Progyny Inc (NAS:PGNY)
$ 23.261 0.35 (1.53%) Market Cap: 2.10 Bil Enterprise Value: 1.82 Bil PE Ratio: 36.30 PB Ratio: 4.55 GF Score: 80/100

Progyny Inc at JPMorgan Healthcare Conference Transcript

Jan 13, 2020 / 07:00PM GMT
Release Date Price: $31.81 (+8.71%)
Anne Elizabeth Samuel
JP Morgan Chase & Co, Research Division - Analyst

Good morning, everybody. Welcome to the JPMorgan Healthcare Conference. My name is Annie Samuel, and I cover Healthcare IT for JPMorgan. It's my pleasure this morning to introduce Progyny. With us this morning is CEO, David Schlanger. We'll be taking questions after the breakout in the Yorkshire room, and there we'll be joined by President, CFO and COO, Pete Anevski as well. And with that, let me turn it over to David.

David J. Schlanger
Progyny, Inc. - CEO & Director

Thanks, Annie, and thanks, everybody, for coming out this morning. I'd like to thank Annie and the rest of the JPMorgan team for giving us the opportunity to tell our story to you this morning. So before I get into the meat of the presentation, I'm just going to pause briefly on this slide, some legal disclaimers regarding any forward-looking statements or non-GAAP financial measures that may be in today's presentation.

Before I get into the details of our business at Progyny, I wanted to give everybody a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot